REG-Invesco Ltd. : Form 8.3 - Spire Healthcare Group Plc <Origin Href="QuoteRef">SPI.L</Origin>

Spire HealthcareAnnouncement

27/10/2017 12:26

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20171027:nGNE5tf2Qd


FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY 
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

 (a) Full name of discloser:                                                                                                                                                                                                      Invesco Ltd.                       
 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.                                       
 (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree                                                                                             Spire Healthcare Group Plc         
 (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:                                                                                                                                                
 (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure                                                                                         26 October 2017                    
 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"                                          Yes: Mediclinic International Plc  

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
1. Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
 Class of relevant security:                                                                       GB00BNLPYF73 1p Ordinary             
                                                                                             Interests             Short positions      
                                                                                         Number              %      Number          %   
 (1) Relevant securities owned and/or controlled:                                      7,252,958           1.80%                        
 (2) Cash-settled derivatives:                                                                                                          
 (3) Stock-settled derivatives (including options) and agreements to purchase/sell:                                                     
 TOTAL:                                                                                7,252,958           1.80%                        

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors'
and other employee options)

 Class of relevant security in relation to which subscription right exists:       
 Details, including nature of the rights concerned and relevant percentages:      

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.
1. Purchases and sales
 Class of relevant security    Purchase/sale    Number of securities    Price per unit  
          Ordinary                Purchase             587,991             2.97 GBP     
          Ordinary                Purchase            1,000,000            3.00 GBP     

 (b)       Cash-settled derivative transactions

 Class of relevant security    Product description e.g. CFD    Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position    Number of reference securities    Price per unit  
                                                                                                                                                                                                                            

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

 Class of relevant security    Product description e.g. call option    Writing, purchasing, selling, varying etc.    Number of securities to which option relates    Exercise price per unit    Type e.g. American, European etc.    Expiry date    Option money paid/ received per unit  
                                                                                                                                                                                                                                                                                          

(ii)        Exercise

 Class of relevant security    Product description e.g. call option    Exercising/ exercised against    Number of securities    Exercise price per unit  
                                                                                                                                                         

(d)        Other dealings (including subscribing for new securities)

 Class of relevant security    Nature of dealing e.g. subscription, conversion    Details    Price per unit (if applicable)  
                                                                                                                             

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

 Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"  
 None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

(b)        Agreements, arrangements or understandings relating to
options or derivatives

 Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"  
 None                                                                                                                                                                                                                                                                                                                                                                                                                                   

(c)        Attachments

 Is a Supplemental Form 8 (Open Positions) attached?    NO  

 Date of disclosure:    27 October 2017  
 Contact name:          Sam Edwards      
 Telephone number:      01491 416 381    

Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service and must also be emailed to the Takeover Panel at
monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is
available for consultation in relation to the Code's disclosure requirements
on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of
Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: Invesco Ltd. via Globenewswire